This is a non-core endpoint: only basic statistics are computed.
Hepatocellular carcinoma
C3_HEPATOCELLU_CARC
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
815 |
4. Check minimum number of eventsNone |
815 |
5. Include endpointsNone |
815 |
6. Filter based on genotype QC (FinnGen only) |
787 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Hepatocellular carcinoma
based on the number of shared cases.
Similar with more cases:
- Hepatocellular carcinoma, including Hilmo
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo
- Malignant neoplasm of digestive organs
- Solid cancers, helper endpoint
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 787 | 124 | 663 |
| Unadjusted period prevalence (%) | 0.26 | 0.04 | 0.30 |
| Median age at first event (years) | 73.00 | 74.46 | 72.73 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 815
- Matched controls
- 8150
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z51.5
ICD-10 Finland
Palliative care
32.2
307.7
323
163
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
53.4
307.7
199
49
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
172.0
307.7
282
25
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
277.7
307.7
276
15
130
Kela drug reimbursment
Malignant tumour
+∞
307.7
375
*
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
307.7
581
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
307.7
783
*
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
37.8
256.7
164
54
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
13.9
243.5
266
275
JN4CD
NOMESCO Finland
Very extensive body CT
46.7
238.6
143
37
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
53.7
233.3
135
30
198
Kela drug reimbursment
Sorafenib
+∞
229.3
209
*
N02AA05
ATC
oxycodone; systemic
8.9
212.5
384
742
A03FA01
ATC
metoclopramide; systemic, rectal
10.4
201.7
277
386
8000/3-C22.0
ICD-O-3
Neoplasm, malignant of liver
+∞
182.3
168
*
R18
ICD-10 Finland
Ascites
27.7
178.3
125
53
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
171.0
158
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
33.0
151.2
99
34
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
30.8
146.4
98
36
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
19.0
139.0
114
69
L01XE05
ATC
[U] sorafenib
+∞
129.7
121
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
30.7
124.3
83
30
JN4AD
NOMESCO Finland
Body CT examination
9.2
123.8
169
226
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
15.0
117.4
109
83
323
Kela drug reimbursment
Sorafenib
+∞
113.2
106
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
20.2
110.3
87
48
WX302
NOMESCO Finland
Thoracal epidural anesthesy
17.5
107.6
91
58
JN4BD
NOMESCO Finland
Extensive body CT
9.3
105.3
139
177
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
103.4
97
*
C03DA01
ATC
spironolactone; oral
5.1
102.5
290
791
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.9
101.9
223
486
A04AA01
ATC
ondansetron; systemic, rectal
19.6
94.2
75
42
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.9
88.7
134
199
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
87.1
82
*
WZC00
NOMESCO Finland
Treatment plan or consultation
4.3
86.1
326
1095
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
+∞
86.0
81
*
127
Kela drug reimbursment
Transplant complication
25.3
85.7
61
26
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
45.3
78.9
47
11
H02AB02
ATC
dexamethasone; systemic
18.9
78.2
63
36
JN3AD
NOMESCO Finland
Abdominal CT examination
5.5
75.8
172
381
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.8
75.5
380
1529
C61
ICD-10 Finland
Malignant neoplasm of prostate
402.7
75.0
74
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
73.0
69
*
L01EX02
ATC
sorafenib; oral
+∞
72.0
68
*
L04AA06
ATC
mycophenolic acid; systemic
16.8
68.1
58
37
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
+∞
63.4
60
*
L04AD02
ATC
tacrolimus; systemic
29.5
62.5
42
15
Z94.4
ICD-10 Finland
Liver transplant status
167.5
59.8
62
*
103
Kela drug reimbursment
Diabetes, insulin-treated
3.2
59.7
415
1974
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
+∞
56.9
54
*
JJC00
NOMESCO Finland
Allogenic transplantation of liver
301.5
55.9
56
*
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
127.0
55.6
59
5
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
54.8
52
*
K76.9
ICD-10 Finland
Liver disease, unspecified
18.9
53.7
43
24
3019
Kela drug reimbursment
Lenvatinib
+∞
52.7
50
*
XX3DW
NOMESCO Finland
Time consuming IT work
6.5
52.3
91
155
A10BA02
ATC
metformin; oral
3.0
51.2
412
2080
1508
Kela drug reimbursment
Lenvatinib
+∞
50.5
48
*
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
10.7
50.1
56
56
A06AD11
ATC
lactulose; oral
3.3
49.1
246
946
A04AA02
ATC
granisetron; systemic, transdermal
506.9
48.9
48
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.9
48.9
371
1804
A10AE04
ATC
insulin glargine; parenteral
3.9
48.8
172
527
C03CA01
ATC
furosemide; systemic
2.9
48.4
459
2509
K92.0
ICD-10 Finland
Haematemesis
6.9
46.9
76
120
WF002
NOMESCO Finland
Radical radiotherapy
77.4
45.5
51
7
L01EX08
ATC
lenvatinib; oral
+∞
45.2
43
*
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.9
45.1
321
1495
176
Kela drug reimbursment
Regorafenib
+∞
42.0
40
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.3
41.5
120
317
N02AX02
ATC
tramadol; systemic, rectal
2.6
40.4
427
2396
A05AA02
ATC
ursodeoxycholic acid; oral
14.3
40.2
37
27
WW500
NOMESCO Finland
Blood transfusion
8.1
39.9
55
72
116
Kela drug reimbursment
Prostate cancer
+∞
39.9
38
*
T90
ICPC
Diabetes non-insulin dependent
2.7
39.4
316
1544
D77
ICPC
Malignant digestive neopl other/NOS
406.2
39.4
39
*
WZC30
NOMESCO Finland
Teaching
3.6
39.3
152
491
A10AB05
ATC
insulin aspart; parenteral
3.7
35.9
127
386
L04AD01
ATC
ciclosporin; systemic
12.1
35.4
36
31
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
362.1
35.2
35
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
362.1
35.2
35
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
11.8
33.8
35
31
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.4
32.8
67
132
369
Kela drug reimbursment
Regorafenib
+∞
32.5
31
*
B01AB10
ATC
tinzaparin; parenteral
4.1
32.3
96
257
TPH07
NOMESCO Finland
Cathetrisation of artery
3.2
31.7
141
494
A10BB12
ATC
glimepiride; oral
3.2
31.6
146
523
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
114.5
30.9
33
*
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
30.0
30.1
40
14
A07AA11
ATC
rifaximin; oral
59.0
29.3
34
6
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
35.2
28.9
37
11
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.6
28.6
207
940
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
28.3
27
*
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
66.5
28.1
32
5
K92.1
ICD-10 Finland
Melaena
3.8
27.7
92
266
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
26.5
27.7
38
15
UJF32
NOMESCO Finland
Coloscopy
2.4
27.4
246
1233
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
39.3
27.3
34
9
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
26.7
219
1052
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
9.5
26.6
32
35
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
9.5
26.6
32
35
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
6.8
26.2
42
65
JJ7LT
NOMESCO Finland
Coagulation of focal hepatic lesion under CT guidance
+∞
26.2
25
*
L01EX05
ATC
regorafenib; oral
+∞
26.2
25
*
TK800
NOMESCO Finland
Hemodialysis
6.7
25.8
42
66
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
25.8
427
2739
SPAT1262
SPAT
Handing over of treatment supplies
2.5
25.7
209
997
JJA44
NOMESCO Finland
Laparoscopic destruction of lesion of liver
+∞
25.1
24
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
25.1
24
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
25.1
24
*
A79
ICPC
Malignancy NOS
134.1
24.7
26
*
A10AE05
ATC
insulin detemir; parenteral
3.6
24.6
86
257
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
57.9
24.2
28
5
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
24.1
23
*
PC2SC
NOMESCO Finland
Liver angiography with X-ray
+∞
24.1
23
*
B01AB05
ATC
enoxaparin; parenteral
2.2
24.0
265
1439
WX402
NOMESCO Finland
General anaesthesia
2.7
23.7
150
633
A10AC01
ATC
insulin (human); parenteral
2.9
23.6
122
462
B18.2
ICD-10 Finland
Chronic viral hepatitis C
22.1
23.6
34
16
I81
ICD-10 Finland
Portal vein thrombosis
29.2
23.3
31
11
C22
ICD-10 Finland
Malignant neoplasm of liver and intrahepatic bile ducts
+∞
23.0
22
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.7
23.0
141
585
L02AE02
ATC
leuprorelin; implant, parenteral
236.4
22.7
23
*
J01MA12
ATC
levofloxacin; systemic
2.4
22.6
198
972
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
22.4
207
1039
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
22.0
21
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
22.0
21
*
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
17.7
21.9
34
20
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
82.4
21.8
24
*
K72.1
ICD-10 Finland
Chronic hepatic failure
82.4
21.8
24
*
N02AA01
ATC
morphine; systemic, rectal
7.4
21.8
32
45
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
225.8
21.7
22
*
A02BC02
ATC
pantoprazole; systemic
2.1
21.7
542
3957
K83.0
ICD-10 Finland
Cholangitis
7.2
21.3
32
46
A10BH01
ATC
sitagliptin; oral
2.6
21.1
136
577
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
7.9
20.9
29
38
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
+∞
20.9
20
*
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
20.9
20
*
JJB30
NOMESCO Finland
Excision of two segments of liver
+∞
20.9
20
*
R4110
NOMESCO Finland
Physiotherapy
2.2
20.6
236
1288
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.4
20.5
159
736
C22.7
ICD-10 Finland
Malignant neoplasm: Other specified carcinomas of liver
+∞
19.9
19
*
D97
ICPC
Liver disease NOS
29.8
19.7
26
9
R4190
NOMESCO Finland
Nutritional therapy
6.8
19.7
31
47
TJA10
NOMESCO Finland
Laparocentesis
107.7
19.6
21
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
6.2
19.6
34
57
B01AB04
ATC
dalteparin; parenteral
4.0
19.2
57
152
C07AA05
ATC
propranolol; systemic
2.4
19.0
146
671
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
18.8
18
*
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
+∞
18.8
18
*
JJB71
NOMESCO Finland
Laparoscopic resection of liver
+∞
18.8
18
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
18.8
18
*
JJ5AT, ,
NOMESCO Finland
+∞
17.8
17
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
17.8
17
*
L01XE21
ATC
[U] regorafenib
+∞
17.8
17
*
J01MA02
ATC
ciprofloxacin; systemic
1.9
17.8
348
2279
R50.9
ICD-10 Finland
Fever, unspecified
2.4
17.6
139
646
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
17.0
133
614
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
64.7
16.8
19
*
JN3GE
NOMESCO Finland
Intraoperative ultrasound examination of abdomen
+∞
16.7
16
*
L02BB03
ATC
bicalutamide; oral
+∞
16.7
16
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
173.4
16.6
17
*
C07AG02
ATC
carvedilol; oral
2.7
16.3
91
357
205
Kela drug reimbursment
Chronic hypertension
1.9
16.3
340
2255
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.8
16.1
51
142
KCD02
NOMESCO Finland
Transurethral resection of bladder
19.0
16.1
24
13
E66.00
ICD-10 Finland
Metabolic syndrome
3.3
15.9
61
193
A10BG03
ATC
pioglitazone; oral
3.9
15.9
47
125
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.5
15.6
38
87
D13.4
ICD-10 Finland
Benign neoplasm: Liver
38.9
15.4
19
5
A06AH03
ATC
naloxegol; oral
18.2
15.2
23
13
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
14.6
14
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
14.6
14
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
14.6
14
*
JJA20
NOMESCO Finland
Open biopsy of liver
81.6
14.6
16
*
A10BH05
ATC
linagliptin; oral
2.8
14.5
76
288
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
152.6
14.5
15
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.6
14.5
48
138
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.8
14.3
45
125
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
19.6
14.3
21
11
D64.9
ICD-10 Finland
Anaemia, unspecified
2.2
14.0
128
630
PC1BC
NOMESCO Finland
Extensive angiography of aorta and abdominal arteries
24.3
13.8
19
8
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.9
13.0
65
240
160
Kela drug reimbursment
exenatide
4.6
12.9
31
70
WVA20
NOMESCO Finland
Medicine administration
4.7
12.9
30
66
WW200, ,
SPAT
0.3
12.8
41
1171
XX4BW, ,
NOMESCO Finland
71.0
12.6
14
*
JJA43
NOMESCO Finland
Destruction of lesion of liver
+∞
12.5
12
*
XJA00
NOMESCO Finland
Intraoperative abdominal ultrasonography
+∞
12.5
12
*
L01XE29
ATC
[U] lenvatinib
+∞
12.5
12
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.9
12.4
59
212
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.9
12.4
181
1055
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.6
12.4
75
306
ZX120
NOMESCO Finland
Intravenous
2.7
12.4
70
276
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
5.5
12.4
24
45
A41.8
ICD-10 Finland
Other specified sepsis
4.3
12.3
32
77
A10BB01
ATC
glibenclamide; oral
2.5
12.3
81
344
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
12.3
150
823
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.6
12.2
41
119
N05CF01
ATC
zopiclone; oral
1.8
12.2
274
1822
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.0
12.2
55
192
K29.6
ICD-10 Finland
Other gastritis
6.1
12.2
21
35
XCK10
NOMESCO Finland
Photography of fundus of eye
2.2
12.0
103
493
UJF30
NOMESCO Finland
Ileoscopy through colon
2.5
11.9
78
331
UJK02
NOMESCO Finland
ERCP
4.1
11.8
33
84
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.7
11.5
260
1726
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.0
11.5
53
187
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
5.1
11.5
24
48
PJA12
NOMESCO Finland
Sentinel node biopsy
121.7
11.5
12
*
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
35.6
11.3
14
*
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.8
11.3
57
212
K83.1
ICD-10 Finland
Obstruction of bile duct
8.7
11.1
23
27
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.3
11.1
29
926
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
43.9
10.9
13
*
JAH01
NOMESCO Finland
Laparoscopy
4.4
10.8
27
63
L04AX01
ATC
azathioprine; systemic
3.4
10.5
37
111
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
111.4
10.4
11
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
10.4
10
*
L01BC06
ATC
capecitabine; oral
+∞
10.4
10
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
10.4
114
599
A10BX07
ATC
[U] liraglutide
5.2
10.4
21
41
WPB10
NOMESCO Finland
Making a convalescent care decision
33.0
10.4
13
*
K70.4
ICD-10 Finland
Alcoholic hepatic failure
19.1
10.3
15
8
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.9
10.0
47
168
JAH00
NOMESCO Finland
Laparotomy
3.9
10.0
29
76
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
13.6
9.7
16
12
C10AA05
ATC
atorvastatin; oral
0.6
9.7
208
2998
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
3.5
9.7
33
97
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
55.7
9.7
11
*
Z2446
NOMESCO Finland
Social worker
2.6
9.7
55
218
SPAT1109
SPAT
Analgesia with portable analgesic pump
15.2
9.5
15
10
ZX050
NOMESCO Finland
Stereotactic radiotherapy
101.2
9.4
10
*
J01FF01
ATC
clindamycin; systemic
1.7
9.4
205
1337
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.1
9.4
89
442
1550A
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Liver, primary
+∞
9.4
9
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
9.4
9
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
9.4
9
*
JKA20
NOMESCO Finland
Cholecystectomy
3.2
9.3
37
120
K70.0
ICD-10 Finland
Alcoholic fatty liver
7.4
9.3
21
29
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
3.0
9.2
41
142
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
13.9
9.2
15
11
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
9.2
100
524
ZX108
NOMESCO Finland
Inhalation
11.6
9.1
16
14
Z2221
NOMESCO Finland
Medical doctor
1.7
9.0
183
1171
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
8.9
91
465
ZX090
NOMESCO Finland
Other technic of radiotherapy
24.3
8.9
12
5
A10BD07
ATC
metformin and sitagliptin; systemic
2.6
8.8
53
216
XF612
NOMESCO Finland
Measurement of central venous pressure
50.5
8.7
10
*
ZXE00
NOMESCO Finland
One hour or less
1.6
8.7
267
1897
C10AX09
ATC
ezetimibe; oral
0.4
8.7
38
945
K70.1
ICD-10 Finland
Alcoholic hepatitis
8.3
8.6
18
22
Z3231
NOMESCO Finland
Registered nurse
1.7
8.6
197
1299
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.2
8.5
34
111
K76.7
ICD-10 Finland
Hepatorenal syndrome
20.3
8.5
12
6
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
20.3
8.5
12
6
XW000
NOMESCO Finland
Bone marrow biopsy
3.0
8.4
36
122
N06DX01
ATC
memantine; oral
0.3
8.4
18
649
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
91.0
8.4
9
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
8.4
276
1991
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
8.3
8
*
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
+∞
8.3
8
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
8.3
8
*
JJB40
NOMESCO Finland
Excision of segments II, III and IV of liver
+∞
8.3
8
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
8.3
8
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
8.3
8
*
JJB20
NOMESCO Finland
Excision of single segment of liver
+∞
8.3
8
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
8.3
8
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
8.3
8
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
8.3
8
*
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.4
8.3
56
241
ZZA00
NOMESCO Finland
Split skin graft
3.6
8.3
27
77
A46
ICD-10 Finland
Erysipelas
1.8
8.3
140
847
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.3
8.3
62
280
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
8.1
222
1529
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
33.7
8.1
10
*
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
33.7
8.1
10
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
17.4
8.1
12
7
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
9.0
8.1
16
18
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
22.3
8.0
11
5
WPA13
NOMESCO Finland
Palliative consultation
22.3
8.0
11
5
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.3
8.0
20
47
H02AB04
ATC
methylprednisolone; systemic
1.9
7.9
112
641
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.6
7.9
44
173
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.4
7.8
50
1066
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.2
7.8
66
313
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
10.9
7.8
14
13
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
7.8
540
4559
WX892
NOMESCO Finland
Monitored bed care
2.1
7.8
74
369
UJD02
NOMESCO Finland
Gastroscopy
2.5
7.7
50
211
K72.9
ICD-10 Finland
Hepatic failure, unspecified
7.5
7.7
17
23
A10BB07
ATC
glipizide; oral
3.2
7.6
30
97
C09BA02
ATC
enalapril and diuretics; systemic
2.0
7.5
89
480
A10AB04
ATC
insulin lispro; parenteral
3.1
7.5
30
98
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
80.8
7.4
8
*
Y77
ICPC
Malignant neoplasm prostate
80.8
7.4
8
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
80.8
7.4
8
*
A98
ICPC
Health maint/preventive medicine
0.7
7.4
537
6097
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
7.3
75
384
PG1PT
NOMESCO Finland
Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified
9.5
7.3
14
15
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
7.3
7
*
115
Kela drug reimbursment
Breast cancer
+∞
7.3
7
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
7.3
7
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
7.3
7
*
E0000UV, ,
ATC
1.5
7.3
264
1934
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
4.4
7.2
18
42
K76.89
ICD-10 Finland
Other specified diseases of liver
15.9
7.2
11
7
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
15.9
7.2
11
7
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.3
7.2
53
238
A10BG02
ATC
rosiglitazone; oral
3.5
7.2
24
70
D05AX52
ATC
calcipotriol, combinations; topical
2.5
7.1
45
188
E66.01
ICD-10 Finland
Obesity due to excess calories
2.4
7.1
48
207
A10BX04
ATC
[U] exenatide
6.1
7.1
18
30
JN1AD
NOMESCO Finland
CT examination of upper part of abdomen
12.2
7.1
12
10
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.9
7.1
33
118
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.7
7.0
36
136
K51.5
ICD-10 Finland
Left sided colitis
3.6
6.9
22
62
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.6
6.9
38
149
WX002
NOMESCO Finland
Sedation and analgesia
1.7
6.9
146
940
B02AA02
ATC
tranexamic acid; systemic
2.2
6.8
57
270
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
9.4
6.8
13
14
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.7
6.8
36
138
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
40.4
6.8
8
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
40.4
6.8
8
*
K74.0
ICD-10 Finland
Hepatic fibrosis
16.9
6.8
10
6
177
Kela drug reimbursment
Insulin glargine 300 U / ml
3.9
6.7
19
49
D02AE01
ATC
carbamide; topical
2.3
6.7
51
232
WX882
NOMESCO Finland
High dependency care
3.0
6.7
28
94
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.2
6.6
5
287
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
0.1
6.6
*
243
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
2.5
6.6
40
164
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
8.8
6.6
13
15
V03AE01
ATC
polystyrene sulfonate; oral
3.9
6.6
19
50
A10BH02
ATC
vildagliptin; oral
3.1
6.5
27
90
ZXC40
NOMESCO Finland
Use of ultrasound
10.1
6.5
12
12
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
2.8
6.5
31
112
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.3
6.5
24
75
K76.6
ICD-10 Finland
Portal hypertension
70.4
6.4
7
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
70.4
6.4
7
*
L04AA18
ATC
[U] everolimus
70.4
6.4
7
*
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
70.4
6.4
7
*
PC2DE
NOMESCO Finland
Ultrasound examination of liver vasculature with Doppler method
70.4
6.4
7
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
70.4
6.4
7
*
R10.0
ICD-10 Finland
Acute abdomen
3.1
6.4
26
86
M04AA01
ATC
allopurinol; systemic
1.6
6.4
152
1006
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
6.4
59
291
C10AA07
ATC
rosuvastatin; oral
0.6
6.4
117
1796
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
9.3
6.3
12
13
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
9.3
6.3
12
13
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.5
6.3
40
168
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
18.2
6.3
9
5
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
6.3
6
*
L04AH02
ATC
everolimus; oral
+∞
6.3
6
*
L04AA10
ATC
[U] sirolimus
+∞
6.3
6
*
8000/3-C80.9
ICD-O-3
Neoplasm, malignant of unknown primary site
+∞
6.3
6
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
+∞
6.3
6
*
C22.2
ICD-10 Finland
Malignant neoplasm: Hepatoblastoma
+∞
6.3
6
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
6.3
6
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
6.3
6
*
WPA43, ,
SPAT
+∞
6.3
6
*
I85
ICD-10 Finland
Oesophageal varices
+∞
6.3
6
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
6.3
6
*
L03AA13
ATC
pegfilgrastim; parenteral
26.9
6.2
8
*
I86.4
ICD-10 Finland
Gastric varices
26.9
6.2
8
*
RS220, ,
NOMESCO Finland
5.8
6.2
16
28
E66.8
ICD-10 Finland
Other obesity
3.0
6.2
26
88
162
Kela drug reimbursment
liraglutide
4.2
6.1
16
39
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
12.6
6.1
10
8
K74.3
ICD-10 Finland
Primary biliary cirrhosis
8.7
6.1
12
14
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.3
6.1
16
512
H02AB06
ATC
prednisolone; systemic
1.4
6.0
342
2718
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
247
143
24.35
315.40
5.1
2.3
44.28
33.44
umol/l
3.71
236
128
291
96
46.59
307.65
3.7
1.9
256.90
72.20
u/ml
0.56
260
68
416
293
27.96
307.65
3.7
1.4
3.60
2.86
ug/l
1.12
359
219
368
458
13.83
301.25
6.1
1.8
0.17
0.19
g/l
5.63
353
403
156
58
33.03
234.42
2.2
1.6
35.04
28.47
u/ml
0.17
148
50
185
133
17.70
208.97
1.5
1.1
56.92
90.00
titre
0.63
13
11
139
66
25.19
190.02
1.3
1.0
1.64
1.58
g/l
0.50
134
57
317
575
8.39
182.83
11.7
2.3
15.89
10.99
umol/l
1.23
300
495
267
580
6.36
124.50
12.7
6.3
9.20
11.60
mmol/l
4.38
256
542
73
36
22.17
97.02
1.4
1.1
—
—
—
0
0
220
519
5.44
91.31
2.6
1.8
1.63
1.71
%
0.80
198
423
421
1641
4.24
91.28
13.1
2.6
65.00
36.61
u/l
5.23
411
1549
55
14
42.06
90.66
2.3
2.3
957.33
1421.50
e6/l
—
33
8
534
2500
4.29
88.32
16.6
3.6
31.39
34.94
g/l
31.81
514
2268
369
1369
4.10
84.49
16.4
3.6
73.73
79.94
%
5.21
359
1324
560
2790
4.22
82.79
24.7
3.8
23.05
13.36
umol/l
10.62
545
2606
148
281
6.21
77.10
1.5
1.3
1.66
1.16
g/l
1.80
133
253
94
108
9.71
76.49
1.2
1.4
—
—
—
0
0
261
827
4.17
73.13
2.6
2.6
25.35
22.69
%
1.36
236
694
268
869
4.11
72.66
4.7
2.5
0.77
0.83
mmol/l
9.67
257
792
158
346
5.42
70.25
2.0
1.8
13.77
11.19
g/l
6.82
145
311
261
879
3.90
66.31
2.5
2.5
2.28
2.22
g/l
0.62
245
802
396
1754
3.45
65.67
5.9
2.3
57.15
60.29
u/l
0.41
383
1603
94
135
7.74
63.53
5.5
2.5
1.74
1.76
mg/l
0.05
86
118
67
64
11.32
61.98
1.2
1.4
117.17
109.88
u/ml
—
6
10
58
47
13.21
59.54
1.3
1.3
73.33
275.00
titre
—
9
6
263
961
3.56
58.16
2.6
2.5
13.21
12.45
umol/l
0.77
251
874
168
457
4.37
56.66
3.8
2.2
30.68
33.46
u/l
0.56
151
370
67
75
9.64
55.29
1.2
1.2
392.13
257.15
u/ml
1.83
47
39
69
82
9.10
54.39
1.2
1.1
—
—
—
0
0
545
3188
3.14
52.04
24.8
20.5
1.33
1.47
inr
3.36
148
891
65
84
8.32
47.82
11.3
5.6
820.68
498.29
iu/ml
0.31
31
14
41
29
14.83
45.34
1.1
1.0
—
—
—
0
0
440
2448
2.73
43.27
4.8
2.3
—
—
—
0
0
285
1274
2.90
42.83
4.2
2.2
—
—
—
0
0
41
39
11.02
37.80
1.0
1.0
278.75
289.59
mg/l
0.26
36
34
203
811
3.00
36.76
7.7
5.1
1.07
1.02
mmol/l
1.06
190
733
514
3277
2.54
35.44
13.1
3.1
198.87
54.29
u/l
36.34
493
2958
476
2945
2.48
34.80
14.0
5.9
4.21
4.54
e9/l
2.10
431
2526
456
2940
2.25
27.98
10.7
5.6
1.18
1.21
mmol/l
7.07
393
2495
31
31
10.36
27.52
1.1
1.2
—
—
—
0
0
69
166
4.45
26.65
2.0
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
82
225
3.94
26.59
2.6
2.7
0.22
0.35
u/ml
4.25
43
130
106
348
3.35
26.28
11.2
9.0
—
—
—
0
0
422
2695
2.17
25.79
9.8
5.2
1.18
1.20
mmol/l
5.85
409
2386
179
799
2.59
25.33
9.2
6.5
12.34
11.07
kpa
3.07
172
758
179
799
2.59
25.33
9.2
6.5
4.98
5.12
kpa
1.25
172
760
161
683
2.69
25.24
3.9
3.1
0.94
2.14
mmol/l
3.55
123
556
511
3585
2.14
23.65
12.3
4.6
7.83
6.96
mmol/l
8.70
493
3363
175
798
2.52
23.54
9.1
6.5
0.42
1.36
mmol/l
2.53
143
624
150
642
2.64
22.96
10.1
7.2
117.33
123.30
g/l
2.53
145
629
30
39
7.95
21.80
1.0
1.0
—
—
—
0
0
281
1617
2.13
21.56
4.2
3.0
1.12
0.37
e6/l
2.08
230
1221
145
629
2.59
21.51
4.4
3.3
—
—
—
0
0
169
792
2.43
21.25
1.7
1.2
4.62
2.99
g/l
9.02
141
444
112
439
2.80
20.24
3.7
2.4
63.70
59.84
ml/min/173m2
0.36
57
172
187
943
2.28
19.74
3.2
2.8
1.01
1.22
e6/l
0.34
115
525
569
4317
2.05
19.33
27.4
5.2
153.34
77.34
u/l
40.05
549
3957
298
1810
2.02
19.33
4.3
3.1
78.00
102.87
e6/l
0.23
243
1393
191
993
2.21
18.61
3.1
2.7
0.68
0.99
e6/l
1.79
121
570
377
2536
1.91
17.71
8.4
5.5
22.71
25.31
%
4.31
356
2337
101
414
2.64
16.63
1.9
1.5
—
—
—
0
0
368
2520
1.84
15.81
8.0
5.4
61.29
59.05
%
2.78
347
2328
75
271
2.95
15.65
2.0
1.7
1.39
2.16
ug/l
0.63
70
233
23
12
19.68
15.62
1.1
1.1
—
—
—
0
0
319
2119
1.83
14.90
3.9
2.8
183.44
162.05
ug/l
0.69
298
1917
309
2037
1.83
14.76
4.9
3.5
77.31
101.17
e6/l
0.31
251
1478
257
1612
1.87
14.32
2.9
2.2
3.77
2.95
mg/l
4.74
225
1346
322
2174
1.80
14.05
4.4
3.0
—
—
—
0
0
33
74
4.61
13.88
1.1
1.2
—
—
—
0
0
25
22
11.68
13.86
3.5
2.2
45880.00
42236.36
ug/l
0.45
25
22
186
1065
1.97
13.56
6.2
2.1
2.50
2.44
mmol/l
7.34
175
886
189
1090
1.96
13.49
2.0
1.8
—
—
—
0
0
99
450
2.37
13.01
5.2
3.1
1.21
1.22
mmol/l
0.89
92
378
325
2238
1.75
13.00
4.4
3.9
11.22
8.07
mg/mmol
0.76
234
1498
273
1798
1.78
12.68
6.4
2.0
2.31
2.34
mmol/l
2.87
255
1451
206
1259
1.85
12.17
3.7
2.4
5.06
3.53
e6/l
1.53
194
1117
481
3734
1.70
12.10
5.0
4.2
524.38
1808.83
e6/l
—
8
75
310
2142
1.72
12.02
3.7
3.2
7.19
7.94
mmol/l
2.71
250
1789
20
20
10.22
10.55
1.8
1.3
—
—
—
0
0
301
2131
1.65
10.27
3.6
3.3
462.28
178.11
mg/l
0.50
226
1443
137
773
1.93
10.22
2.0
1.8
—
—
—
0
0
136
774
1.91
9.87
2.1
1.8
—
—
—
0
0
92
472
2.07
8.94
9.1
7.1
23.18
24.63
mmol/l
2.35
87
451
221
3093
0.61
8.90
3.4
3.9
24.10
24.17
%
0.02
93
1537
12
7
17.37
8.09
1.5
1.4
84.25
77.00
nmol/l
—
12
7
36
130
2.85
7.57
3.4
2.5
14.61
16.20
%
1.06
15
73
77
397
2.04
7.38
1.7
1.5
—
—
—
0
0
167
1095
1.66
7.34
1.7
1.6
3.30
1.42
mg/l
3.20
142
846
16
22
7.40
7.21
1.6
1.4
—
—
—
0
0
24
70
3.50
7.16
3.4
2.9
1.95
1.25
%
0.31
19
56
24
70
3.50
7.16
2.8
1.8
89.71
89.71
%
0.00
24
70
96
540
1.88
7.16
2.3
1.6
66.24
66.72
g/l
0.20
84
475
229
1639
1.55
6.96
4.3
2.6
5021.49
8301.59
umol/l
0.44
203
1397
141
2103
0.60
6.94
2.4
2.7
0.86
0.75
ug/l
0.76
91
1469
10
6
16.85
6.75
1.0
1.0
—
—
—
0
0
30
109
2.82
6.27
1.6
1.5
—
—
—
0
0
132
848
1.66
6.23
2.5
1.9
1.99
1.73
%
1.91
119
733
81
452
1.88
6.19
3.5
1.7
410.25
368.33
nmol/l
0.98
75
400
24
79
3.10
5.96
1.7
1.5
—
—
—
0
0
488
5562
0.69
5.85
6.1
4.9
4.03
4.30
mmol/l
7.18
440
5065
12
15
8.10
5.85
1.2
2.0
—
—
—
0
0
112
704
1.69
5.73
2.9
3.2
238.89
272.86
ng/l
0.41
102
658
15
29
5.25
5.41
1.5
1.4
1.70
7.00
u/l
—
10
24
30
119
2.58
5.34
1.6
1.5
—
—
—
0
0
510
5732
0.71
5.27
6.3
5.5
2.33
2.50
mmol/l
4.53
456
5183
486
5502
0.71
5.20
5.9
4.8
1.19
1.36
mmol/l
16.23
433
4970
18
54
3.39
5.19
1.8
1.6
—
—
—
0
0
71
409
1.81
4.93
1.8
1.7
—
—
—
0
0
58
317
1.89
4.76
1.7
1.6
1.11
1.46
g/l
2.32
49
266
316
3805
0.72
4.74
4.1
4.0
2.15
2.12
ug/l
0.04
257
3370
186
1372
1.46
4.68
4.3
4.2
447.56
493.36
ng/l
0.08
164
1211
12
22
5.52
4.61
1.9
1.3
—
—
—
0
0
473
5333
0.73
4.53
5.5
4.3
1.43
1.28
mmol/l
3.03
422
4772
49
258
1.96
4.50
5.2
4.4
2.18
1.52
mmol/l
0.87
49
253
24
95
2.57
4.33
1.3
1.3
8.73
7.10
u/l
0.46
16
79
508
5649
0.73
4.30
5.8
5.0
6.89
6.18
mmol/l
13.97
450
5045
29
131
2.26
3.97
1.1
1.4
337.20
282.38
ug/g
0.70
15
80
32
151
2.16
3.95
1.4
1.4
—
—
—
0
0
14
39
3.63
3.71
1.8
1.6
—
—
—
0
0
40
212
1.93
3.65
2.4
1.4
34.41
37.52
mg/l
0.25
29
173
40
213
1.92
3.60
2.4
1.4
51.62
49.19
mg/l
0.11
29
173
15
52
2.92
3.48
1.3
1.2
—
—
—
0
0
37
195
1.94
3.44
2.1
1.4
0.18
0.00
g/l
0.76
28
175
20
82
2.48
3.40
3.2
3.0
54.95
59.54
%
0.81
20
82
41
225
1.87
3.39
1.9
2.2
131.06
104.73
ug/min
0.14
25
142
111
1524
0.69
3.39
2.3
1.6
1.67
1.33
mmol/l
2.82
104
1247
35
182
1.96
3.38
2.1
1.4
0.00
0.00
g/l
-0.00
26
162
27
128
2.15
3.33
1.7
1.5
—
—
—
0
0
17
67
2.57
3.14
1.8
1.5
—
—
—
0
0
121
887
1.43
3.10
1.2
1.2
1.67
1.65
u/ml
0.01
24
244
183
1439
1.35
3.08
1.8
1.8
1149.00
1128.28
nmol/l
0.11
135
1088
22
99
2.26
3.08
1.8
2.3
4.22
4.11
mmol/l
0.57
22
99
22
99
2.26
3.08
1.8
2.3
106.68
105.24
mmol/l
0.82
22
99
19
81
2.38
3.00
3.2
2.7
3.62
4.81
e9/l
1.37
19
81
9
21
4.32
3.00
1.7
1.6
—
—
—
0
0
18
76
2.40
2.91
2.1
1.5
12790.08
37016.38
e6/l
0.47
12
45
33
178
1.89
2.90
2.2
1.4
0.00
0.00
g/l
-0.00
25
161
9
22
4.12
2.88
1.7
1.6
—
—
—
0
0
34
189
1.83
2.74
1.3
1.2
—
—
—
0
0
262
2199
1.28
2.73
2.8
3.2
1473.94
1850.49
ng/l
0.49
230
1908
6
10
6.03
2.70
1.7
1.4
—
—
—
0
0
66
441
1.54
2.69
2.8
3.4
1.24
1.86
mmol/l
0.58
38
322
14
55
2.57
2.62
2.5
2.4
—
—
—
0
0
66
444
1.53
2.62
2.8
3.9
86.24
99.34
ng/l
0.81
61
382
69
470
1.51
2.59
2.9
3.5
4.89
5.19
kpa
2.30
59
441
24
121
2.01
2.58
1.4
1.7
—
—
—
0
0
5
7
7.18
2.55
1.4
1.0
—
—
—
0
0
38
225
1.72
2.51
2.2
1.4
1.21
0.50
g/l
0.48
28
186
36
210
1.75
2.50
1.5
1.6
—
170.00
—
0
10
0
64
0.00
2.43
0.0
1.0
—
602.78
—
0
36
0
64
0.00
2.43
0.0
1.0
—
45.67
—
0
36
15
64
2.37
2.40
1.5
1.4
—
—
—
0
0
13
52
2.52
2.36
1.2
1.2
1.40
2.82
u/ml
—
5
17
7
17
4.14
2.36
1.3
1.8
37.66
64.37
ug/l
—
7
17
9
28
3.24
2.31
1.4
1.3
—
—
—
0
0
9
28
3.24
2.31
1.4
1.3
—
—
—
0
0
9
28
3.24
2.31
1.7
1.5
—
—
—
0
0
183
1496
1.29
2.31
1.8
1.7
435.60
15617744.69
pmol/l
1.00
147
1223
18
85
2.14
2.30
1.6
1.4
—
—
—
0
0
303
2631
1.24
2.29
4.5
4.2
33.86
82.53
ng/l
1.84
262
2048
585
6212
0.79
2.27
56.0
21.6
124.18
136.86
g/l
49.45
564
6042
36
217
1.69
2.26
2.2
1.4
36.22
36.84
g/l
0.22
28
179
585
6211
0.79
2.25
55.5
21.4
4.16
4.49
e12/l
31.63
558
5932
585
6209
0.80
2.23
55.5
21.4
191.77
231.60
e9/l
22.78
559
5964
585
6208
0.80
2.22
56.1
21.6
37.21
40.19
%
20.34
518
5600
508
5469
0.81
2.18
10.5
6.7
45.37
41.52
mmol/mol
9.25
461
4989
16
74
2.19
2.15
1.4
1.4
—
—
—
0
0
7
19
3.71
2.15
4.1
2.0
—
—
—
0
0
6
14
4.31
2.15
1.5
1.1
11.73
9.45
ug/l
—
6
14
17
81
2.12
2.14
1.3
1.4
—
—
—
0
0
17
81
2.12
2.14
1.3
1.4
—
—
—
0
0
40
252
1.62
2.13
2.5
1.4
3.06
3.05
g/l
0.03
32
214
310
2723
1.22
2.06
4.4
3.5
0.01
0.01
estimate
0.15
73
499
42
272
1.57
2.02
2.4
1.4
7.70
7.47
g/l
0.34
34
233
10
38
2.65
2.01
2.4
1.7
—
—
—
0
0
307
2703
1.22
1.98
5.9
4.7
0.00
0.00
estimate
-0.00
67
457
15
71
2.13
1.93
1.5
2.6
870.25
641.56
ml
—
8
50
42
276
1.55
1.91
1.6
1.7
—
—
—
0
0
470
5064
0.83
1.86
4.8
4.1
2.61
2.04
mu/l
4.26
415
4486
6
17
3.55
1.84
1.0
1.1
1232.50
1649.71
miu/ml
—
6
17
12
53
2.28
1.81
1.2
1.2
1.98
1.60
nmol/l
0.38
12
45
53
741
0.70
1.80
1.2
1.3
15.45
40.44
iu/ml
5.23
19
217
41
272
1.53
1.80
2.4
1.4
4.29
3.75
g/l
1.52
34
234
41
272
1.53
1.80
2.4
1.4
—
—
—
0
0
39
256
1.55
1.79
2.1
1.4
13.26
10.63
g/l
1.91
30
218
38
250
1.55
1.74
1.6
1.5
—
—
—
0
0
309
2755
1.20
1.69
4.4
3.5
0.00
0.00
estimate
-0.00
59
437
13
253
0.51
1.68
1.6
1.9
—
—
—
0
0
10
41
2.46
1.64
1.5
1.7
13.40
15.31
umol/l
—
10
34
10
41
2.46
1.64
1.0
1.2
—
—
—
0
0
19
105
1.83
1.64
1.4
1.2
—
—
—
0
0
34
222
1.55
1.62
1.9
3.2
—
—
—
0
0
242
2119
1.20
1.60
2.9
2.1
73.90
76.74
nmol/l
0.68
219
1805
31
201
1.56
1.53
1.7
1.7
51.53
38.82
u/l
1.57
23
164
51
695
0.72
1.52
1.1
1.2
21.28
13.72
u/ml
0.22
17
244
5
15
3.35
1.52
1.2
1.1
—
—
—
0
0
5
15
3.35
1.52
1.2
1.1
—
—
—
0
0
5
15
3.35
1.52
1.2
1.1
—
—
—
0
0
240
2111
1.19
1.50
4.8
3.7
—
—
—
0
0
176
1507
1.21
1.47
4.9
3.7
0.00
0.01
estimate
0.50
55
429
12
59
2.05
1.44
1.3
1.4
—
—
—
0
0
12
59
2.05
1.44
1.2
1.3
—
—
—
0
0
12
59
2.05
1.44
1.3
1.4
—
—
—
0
0
25
157
1.61
1.42
1.5
1.4
—
—
—
0
0
25
157
1.61
1.42
1.5
1.4
—
—
—
0
0
495
5252
0.85
1.41
37.9
13.8
74.04
73.04
ml/min/173m2
0.41
444
4242
232
2046
1.19
1.40
2.1
2.2
201.25
301.77
u/l
0.96
220
1896
572
5988
0.85
1.32
31.9
9.2
43.36
26.42
u/l
30.29
556
5675
5
18
2.79
1.28
1.4
1.2
—
—
—
0
0
582
6075
0.85
1.25
45.8
18.5
4.06
4.03
mmol/l
1.31
562
5868
365
3937
0.87
1.22
4.2
3.3
14.60
15.08
pmol/l
3.18
322
3470
10
49
2.05
1.22
1.1
1.2
109.10
113.69
%
—
10
42
47
350
1.36
1.20
3.6
2.5
0.67
0.30
e6/l
0.50
47
345
11
57
1.94
1.17
1.0
1.2
—
—
—
0
0
582
6062
0.86
1.15
45.6
18.4
137.93
139.74
mmol/l
36.58
564
5858
7
31
2.27
1.10
1.0
1.0
—
—
—
0
0
5
21
2.39
1.09
4.6
3.4
—
—
—
0
0
5
21
2.39
1.09
1.8
1.1
791.60
269.74
iu/ml
—
5
21
12
68
1.78
1.01
1.8
1.3
—
—
—
0
0
9
49
1.85
0.99
1.3
1.4
—
—
—
0
0
5
23
2.18
0.98
1.2
1.2
—
—
—
0
0
5
23
2.18
0.98
1.2
1.2
—
—
—
0
0
10
54
1.86
0.97
1.2
1.1
—
—
—
0
0
9
51
1.77
0.94
1.4
1.2
—
—
—
0
0
86
721
1.22
0.92
2.3
2.6
7.02
7.30
ug/l
0.04
69
626
6
28
2.15
0.91
1.3
1.2
—
—
—
0
0
8
42
1.91
0.88
2.3
2.3
—
—
—
0
0
6
31
1.94
0.84
1.2
1.5
—
—
—
0
0
6
31
1.94
0.84
1.2
1.5
—
—
—
0
0
6
32
1.88
0.82
1.5
1.2
—
—
—
0
0
0
27
0.00
0.77
0.0
1.8
—
934.33
—
0
27
0
28
0.00
0.76
0.0
2.3
—
—
—
0
0
9
53
1.71
0.75
1.3
1.4
—
—
—
0
0
20
142
1.42
0.73
1.2
1.2
—
—
—
0
0
11
171
0.64
0.72
1.3
1.4
—
—
—
0
0
580
5615
1.11
0.71
38.6
15.0
33.73
27.57
mg/l
3.97
558
4445
20
143
1.41
0.70
1.2
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
27
1.86
0.68
1.0
1.2
—
—
—
0
0
11
165
0.66
0.63
1.1
1.0
—
—
—
0
0
8
49
1.64
0.62
1.5
1.2
—
—
—
0
0
8
50
1.61
0.61
1.5
1.2
—
—
—
0
0
8
50
1.61
0.61
1.5
1.2
—
—
—
0
0
8
50
1.61
0.61
1.5
1.2
—
—
—
0
0
8
51
1.57
0.60
1.5
1.2
—
—
—
0
0
69
797
0.85
0.60
4.1
4.9
32.56
32.55
%
0.00
52
522
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
10
150
0.66
0.58
1.3
1.4
—
—
—
0
0
8
55
1.46
0.56
1.1
1.2
—
—
—
0
0
9
61
1.48
0.54
1.3
1.2
2.42
0.61
nmol/l
—
9
56
34
280
1.22
0.49
2.1
3.8
23.37
24.78
mmol/l
1.99
29
256
7
45
1.56
0.49
1.1
1.2
—
—
—
0
0
7
45
1.56
0.49
1.1
1.2
—
—
—
0
0
7
45
1.56
0.49
1.1
1.2
—
—
—
0
0
291
2768
1.08
0.47
2.1
2.1
82.25
91.35
pmol/l
2.51
137
1490
153
1647
0.91
0.45
1.7
1.6
15.72
19.43
nmol/l
3.10
133
1371
54
472
1.15
0.43
1.3
1.3
—
—
—
0
0
8
56
1.43
0.42
1.0
1.4
620.50
287.09
pmol/l
—
8
45
430
4165
1.07
0.41
5.4
3.9
24.03
12.89
mm/h
17.08
389
3769
14
183
0.76
0.41
1.8
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
7.8
—
13.54
—
0
18
8
61
1.31
0.39
1.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
2.9
—
—
—
0
0
0
19
0.00
0.39
0.0
2.9
—
—
—
0
0
9
67
1.35
0.38
1.6
1.5
—
—
—
0
0
12
90
1.34
0.36
1.5
1.1
—
—
—
0
0
16
126
1.28
0.35
1.2
1.2
0.57
0.80
nmol/l
—
10
109
242
2520
0.94
0.31
2.5
2.2
—
—
—
0
0
10
130
0.77
0.29
1.1
1.2
—
79.44
—
0
5
9
121
0.74
0.27
1.0
1.1
—
—
—
0
0
5
73
0.68
0.26
1.2
1.0
—
—
—
0
0
25
216
1.16
0.25
1.2
1.2
9.84
131.45
iu/ml
—
7
85
9
75
1.20
0.25
3.8
4.7
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
14.10
—
0
6
20
174
1.15
0.20
1.3
1.2
—
—
—
0
0
6
52
1.15
0.19
1.0
1.5
—
77.50
—
0
8
10
120
0.83
0.16
1.9
1.1
69.93
21.42
u/l
—
10
107
79
829
0.95
0.15
13.9
7.2
—
—
—
0
0
127
1313
0.96
0.13
5.8
3.8
1.01
1.02
kg/l
1.95
29
217
9
106
0.85
0.13
1.0
1.1
—
—
—
0
0
13
146
0.89
0.10
1.2
1.5
4.00
0.11
iu/ml
—
5
40
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
466
4692
0.98
0.07
51.0
17.1
15.68
15.37
%
0.88
458
4571
11
99
1.11
0.06
1.3
1.3
—
—
—
0
0
48
463
1.04
0.06
2.6
2.3
12.66
15.01
nmol/l
0.85
37
408
13
121
1.08
0.03
1.8
1.7
—
—
—
0
0
17
176
0.97
0.00
1.2
1.4
—
—
—
0
0
12
125
0.96
0.00
1.7
2.0
207.75
223.37
pmol/l
0.29
12
119
11
113
0.97
0.00
2.1
1.5
—
—
—
0
0
15
152
0.99
0.00
1.1
1.8
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
5.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
25.98
—
0
5
0
7
0.00
-0.00
0.0
2.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
8
89
0.90
-0.00
1.1
1.2
—
41.86
—
0
8
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_HEPATOCELLU_CARC – Hepatocellular carcinoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).